Last reviewed · How we verify
Klebsiella Pneumoniae Chronic Bronchitis
Approved treatments
- Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Avelox · Novartis Pharmaceuticals
- Noroxin
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Klebsiella Pneumoniae Chronic Bronchitis patent landscape — cliff calendar, originator estates, attackable patents
- Klebsiella Pneumoniae Chronic Bronchitis treatment landscape brief
- Klebsiella Pneumoniae Chronic Bronchitis treatment updates RSS
Frequently asked questions about Klebsiella Pneumoniae Chronic Bronchitis
What drugs treat Klebsiella Pneumoniae Chronic Bronchitis?
Tracked treatments include Avelox, Noroxin.
What is the treatment for Klebsiella Pneumoniae Chronic Bronchitis?
Standard treatment for Klebsiella Pneumoniae Chronic Bronchitis includes Avelox, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Klebsiella Pneumoniae Chronic Bronchitis patent cliff · Klebsiella Pneumoniae Chronic Bronchitis CI report
- Treatment: Avelox · Bayer AG
- Treatment: Avelox · Novartis Pharmaceuticals
- Treatment: Noroxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing